Transvenous vagal nerve stimulation (VNS) in acute myocardial infarction (AMI) reduces the infarct size and improves long term cardiac function

Kana Fujii, Takahiro Arimura, Keita Saku, Takamori Kakino, Takuya Akashi, Tomomi Ide, Takuya Kishi, Kenji Sunagawa

Research output: Contribution to journalComment/debatepeer-review


VNS is known to have an anti-infarct effect. However, the technical difficulty associated with VNS precludes its application under clinical settings of AMI. We developed a novel technique where we stimulate the vagal nerves transvenously, and evaluated how the VNS affects the infarction size and cardiac function in the long term. We ligated the left anterior descending coronary artery for 3 hours, then reperfused. For transvenous VNS, we performed the field electrical stimulation at the superior vena cava. One month after the ischemia-reperfusion, we compared the infarct size and cardiac function with/without VNS. Transvenous VNS significantly decreased the infarction size by more than 80% (1.1±1.2 vs. 7.8±1.2cm2, p<0.05), doubled left ventricular systolic elastance (13.2±0.6 vs. 6.5±1.7 mmHg/ml, p<0.05), and decreased NT-pro BNP (843±256 vs. 3667±1637 pmol/ml, p<0.05). In conclusion, transvenous VNS in AMI markedly reduces the infarct size and improves cardiac function in the long term.

Original languageEnglish
Pages (from-to)O-86-O-87
JournalTransactions of Japanese Society for Medical and Biological Engineering
Publication statusPublished - Aug 17 2014

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering

Cite this